Poseida Therapeutics Cash from Financing (TTM) Trends

Poseida Therapeutics Inc (PSTX)

3.19 -0.16 (-4.63%) USD | NASDAQ | May 17, 16:00

3.19 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	14.90M
December 31, 2023	16.13M
September 30, 2023	16.18M
June 30, 2023	77.08M
March 31, 2023	77.11M
December 31, 2022	105.16M
September 30, 2022	105.34M
June 30, 2022	31.35M
March 31, 2022	31.39M

Date	Value
December 31, 2021	2.518M
September 30, 2021	2.32M
June 30, 2021	206.99M
March 31, 2021	309.96M
December 31, 2020	313.94M
September 30, 2020	313.92M
June 30, 2020	115.25M
March 31, 2020	72.80M
December 31, 2019	164.37M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

2.32M

Minimum

Sep 2021

313.94M

Maximum

Dec 2020

109.82M

Average

77.10M

Median

Cash from Financing (TTM) Benchmarks